These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27637)

  • 21. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
    Sato M; Arimoto M; Ueno K; Kojima H; Yamasaki T; Sakurai T; Kasahara A
    J Med Chem; 1978 Nov; 21(11):1116-20. PubMed ID: 31476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
    J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic 4-aryltetrahydropyrrolo[3,4-b]indoles.
    Welch WM; Harbert CA; Weissman A
    J Med Chem; 1980 Jun; 23(6):704-7. PubMed ID: 6104734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents.
    Yevich JP; New JS; Smith DW; Lobeck WG; Catt JD; Minielli JL; Eison MS; Taylor DP; Riblet LA; Temple DL
    J Med Chem; 1986 Mar; 29(3):359-69. PubMed ID: 2869146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational properties of butaclamol and isobutaclamol. Regularities in the structures of semirigid neuroleptics.
    Froimowitz M; Matthysse S
    Mol Pharmacol; 1983 Sep; 24(2):243-50. PubMed ID: 6193405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.
    Arnt J; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Eur J Pharmacol; 1982 Dec; 86(2):185-98. PubMed ID: 6130958
    [No Abstract]   [Full Text] [Related]  

  • 28. Is dopamine antagonism a requisite of neuroleptic activity?
    Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
    Hrib NJ; Jurcak JG; Huger FP; Errico CL; Dunn RW
    J Med Chem; 1991 Mar; 34(3):1068-72. PubMed ID: 1672156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
    Ellefson CR; Woo CM; Miller A; Kehr JR
    J Med Chem; 1978 Sep; 21(9):952-7. PubMed ID: 31487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agents.
    Wise LD; Pattison IC; Butler DE; DeWald HA; Lewis EP; Lobbestael SJ; Tecle H; Coughenour LL; Downs DA; Poschel BP
    J Med Chem; 1985 Dec; 28(12):1811-7. PubMed ID: 2866248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics.
    Arnt J; Christensen AV
    Eur J Pharmacol; 1981 Jan; 69(1):107-11. PubMed ID: 6110555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives.
    New JS; Yevich JP; Temple DL; New KB; Gross SM; Schlemmer RF; Eison MS; Taylor DP; Riblet LA
    J Med Chem; 1988 Mar; 31(3):618-24. PubMed ID: 2894466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental evaluation of the possible neuroleptic activity of clomipramine.
    Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1978; 22(3):263-9. PubMed ID: 31334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
    Agai-Csongor E; Nógrádi K; Galambos J; Vágó I; Bielik A; Magdó I; Ignácz-Szendrei G; Keseru GM; Greiner I; Laszlovszky I; Schmidt E; Kiss B; Sághy K; Laszy J; Gyertyán I; Zájer-Balázs M; Gémesi L; Domány G
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5340-4. PubMed ID: 17720494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone: chemical profile of a new class of anxioselective agents.
    Temple DL; Yevich JP; New JS
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):4-10. PubMed ID: 6185470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic-like effect of the AMPA receptor antagonist LY326325 as indicated by suppression of conditioned avoidance response in the rat.
    Mathé JM; Fagerquist MV; Svensson TH
    J Neural Transm (Vienna); 1999; 106(9-10):1003-9. PubMed ID: 10599880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural actions of neuroleptics are not reduced by hypophysectomy.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    J Pharm Pharmacol; 1982 Sep; 34(9):588-90. PubMed ID: 6127386
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of naloxone in laboratory tests predictive of clinical antipsychotic activity.
    Malick JB; Billingsley ML; Kubena RK; Goldstein JM
    Commun Psychopharmacol; 1977; 1(5):475-88. PubMed ID: 23920
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological evaluation of 5-[2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-ethyl]-1,3-dihydro-benzimidazole-2-thione as a potential atypical antipsychotic agent.
    Tomić M; Kundaković M; Butorović B; Vasilev V; Dragović D; Roglić G; Ignjatović DJ; Soskić V; Kostić-Rajacić S
    Pharmazie; 2003 Sep; 58(9):677-8. PubMed ID: 14558499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.